BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 33773558)

  • 1. CD34 is not Expressed by Blasts in a Third of B-ALL Patients and its Negativity is associated with Aberrant Marker Expression: A Retrospective Analysis.
    Garg N; Gupta R; Kotru M
    Asian Pac J Cancer Prev; 2021 Mar; 22(3):919-925. PubMed ID: 33773558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of immunophenotypic markers in pediatric T-cell acute lymphoblastic leukemia.
    Sidhom I; Shaaban K; Soliman S; Ezzat S; El-Anwar W; Hamdy N; Yassin D; Salem S; Hassanein H; Mansour MT
    J Egypt Natl Canc Inst; 2008 Jun; 20(2):111-20. PubMed ID: 20029466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and hematological correlates of aberrant immunophenotypic profiles in adult and pediatric acute myeloid leukemia at presentation.
    Sharma M; Varma N; Singh Sachdeva MU; Bose P; Varma S
    J Cancer Res Ther; 2020; 16(1):105-109. PubMed ID: 32362618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunologic characteristics and prognosis of acute myeloid leukemia M1].
    Zhao F; Chen Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):687-91. PubMed ID: 17708783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of immunophenotypic aberrancies in adult and childhood acute lymphoblastic leukemia: A study from Northern India.
    Sharma M; Sachdeva MU; Varma N; Varma S; Marwaha RK
    J Cancer Res Ther; 2016; 12(2):620-6. PubMed ID: 27461621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the immunophenotype of children treated on the Medical Research Council United Kingdom Acute Lymphoblastic Leukaemia Trial XI (MRC UKALLXI). Medical Research Council Childhood Leukaemia Working Party.
    Hann IM; Richards SM; Eden OB; Hill FG
    Leukemia; 1998 Aug; 12(8):1249-55. PubMed ID: 9697880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen Expression on Blast Cells and Hematological Parameters at Presentation in Acute Lymphoblastic Leukemia Patients.
    Naeem S; Bukhari MH
    J Coll Physicians Surg Pak; 2015 Jun; 25(6):407-11. PubMed ID: 26100991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunophenotyping characteristics of T-cell acute lymphoblastic leukemia].
    Chen LJ; Li JY; Wu YJ; Yang H; Qian SX; Wu HX; Lu H; Xu W; Sheng RL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):692-5. PubMed ID: 17708784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunophenotype characteristics and prognosis of acute leukemia patients with cross expressing lymphoid and myeloid lineage associated antigens].
    Jiang NG; Chen XM; Zhu HL; Zhong L; Zeng TT; Jia YQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1405-9. PubMed ID: 21176339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute myeloid leukemia with t(6;9) (p23;q34): association with myelodysplasia, basophilia, and initial CD34 negative immunophenotype.
    Alsabeh R; Brynes RK; Slovak ML; Arber DA
    Am J Clin Pathol; 1997 Apr; 107(4):430-7. PubMed ID: 9124211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunophenotyping characteristics of adult patients with acute lymphoblastic leukemia in different ages].
    Ma J; Liu YF; Chen SM; Zhang QT; Sun L; Liu LX; Wan DM; Chen SQ; Xie XS; Meng XL; Jiang ZX; Cheng YD; Wang F; Sun H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Aug; 18(4):942-5. PubMed ID: 20723305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD7 is expressed on a subset of normal CD34-positive myeloid precursors.
    Kriegsmann K; Löffler H; Eckstein V; Schulz R; Kräker S; Braun U; Luft T; Hegenbart U; Schönland S; Dreger P; Krämer A; Ho AD; Müller-Tidow C; Hundemer M
    Eur J Haematol; 2018 Sep; 101(3):318-325. PubMed ID: 29797671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency and Prognostic Impact of Aberrant Antigens Expression among Egyptian Adult Acute Leukemia.
    Kaheled O; Aref S; El Menshawy N; Aref M; Ayed M
    Asian Pac J Cancer Prev; 2023 Dec; 24(12):4301-4307. PubMed ID: 38156867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of new markers for minimal residual disease monitoring in B-cell precursor acute lymphoblastic leukemia: CD73 and CD86 are the most relevant new markers to increase the efficacy of MRD 2016; 00B: 000-000.
    Tembhare PR; Ghogale S; Ghatwai N; Badrinath Y; Kunder N; Patkar NV; Bibi AR; Chatterjee G; Arora B; Narula G; Banawali S; Deshpande N; Amare P; Gujral S; Subramanian PG
    Cytometry B Clin Cytom; 2018 Jan; 94(1):100-111. PubMed ID: 27718302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application and prognostic relevance of CD34 detection in immunophenotyping of pediatric acute B lymphoblastic leukemia.
    Zha W; Yuan Y; Yang T; Zhu LJ; Kong WY; Zhuo JJ
    Eur Rev Med Pharmacol Sci; 2024 May; 28(9):3384-3390. PubMed ID: 38766795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunophenotype of acute leukemia and its clinical significance].
    Zhu H; Niu T; Meng W; Xu C; Lei S
    Hua Xi Yi Ke Da Xue Xue Bao; 2002 Jan; 33(1):118-20. PubMed ID: 12599447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Characteristics of T-cell lineage immunophenotype in 95 patients with acute lymphoid leukemia].
    Yuan TT; Liu YR; Chang Y; Hao L; Wang YZ; Jiang B; Huang XJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Oct; 19(5):1134-40. PubMed ID: 22040958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
    Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow cytometric analysis of acute leukemias. Diagnostic utility and critical analysis of data.
    Kaleem Z; Crawford E; Pathan MH; Jasper L; Covinsky MA; Johnson LR; White G
    Arch Pathol Lab Med; 2003 Jan; 127(1):42-8. PubMed ID: 12521365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia: a single-institution experience.
    Plesa C; Chelghoum Y; Plesa A; Elhamri M; Tigaud I; Michallet M; Dumontet C; Thomas X
    Cancer; 2008 Feb; 112(3):572-80. PubMed ID: 18085638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.